Active, not recruitingPhase 2NCT06067048

Zanubrutinib in Primary Cold Agglutinin Disease

Studying Cold agglutinin disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Stichting Hemato-Oncologie voor Volwassenen Nederland
Intervention
Zanubrutinib Oral Capsule(drug)
Enrollment
25 enrolled
Eligibility
18 years · All sexes
Timeline
2024 – 2028

Study locations (10)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06067048 on ClinicalTrials.gov

Other trials for Cold agglutinin disease

Additional recruiting or active studies for the same condition.

See all trials for Cold agglutinin disease →

← Back to all trials